Assessments

A photo of pill packets. 

The pandemic has raised alarm about the potential cutoff of critically important drugs from China and India. But the industry’s global supply chains are nonetheless still largely intact.

Pharmaceutical Trade Remains Resilient in the Face of COVID-19

The pandemic has raised alarm about the potential cutoff of critically important drugs from China and India. But the industry’s global supply chains have nonetheless remained largely intact.

Highlights

United States

China

India

Economics

Environment, Science & Technology

The U.S. and the Balance of Power

China in Transition

India's Own Worst Enemy

The United States and many other countries are heavily dependent on supplies of pharmaceuticals and precursor chemicals from China and India. Widespread shortages resulting from the COVID-19 outbreak remain unlikely. Legislative proposals in the United States to force companies to "reshore" supply chains will likely falter on the increase in costs and regulatory hurdles. 

ASSESSMENTS

Pharmaceutical Trade Remains Resilient in the Face of COVID-19

Subscribe to view this article